You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Dow
Moodys
Merck
Baxter

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,138,456


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,138,456
Title:Lipopeptide compositions and related methods
Abstract: The present disclosure provides novel powder daptomycin formulations which have improved chemical stability and faster reconstitution times when in the solid state. Some examples of the compositions comprise daptomycin and sucrose.
Inventor(s): O'Connor; Sandra (Hudson, NH), Sun; Sophie (Lexington, MA), Naik; Gaauri (Cambridge, MA)
Assignee: Cubist Pharmaceuticals LLC (Kenilworth, NJ)
Application Number:14/096,346
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,138,456
Patent Claim Types:
see list of patent claims
Composition; Formulation; Process;

Drugs Protected by US Patent 9,138,456

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cubist Pharms Llc CUBICIN RF daptomycin POWDER;INTRAVENOUS 021572-003 Jul 6, 2016 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,138,456

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 079127   Start Trial
Australia 2010321531   Start Trial
Brazil 112012012406   Start Trial
Canada 2781666   Start Trial
Chile 2015002412   Start Trial
China 102712677   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Express Scripts
McKinsey
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.